Literature DB >> 384269

Effect of methylene blue and thiol oxidants on pancreatic islet GSH/GSSG ratios and tolbutamide mediated insulin release in vitro.

H P Ammon, M S Akhtar, A Grimm, H Niklas.   

Abstract

Methylene blue (an oxidant of NADPH), diamide (an oxidant of glutathion-SH [GSH]) and tertbutyl hydroperoxide (a substrate of glutathione peroxidase) significantly decreased the GSH content of pancreatic rat islets and decreased their GSH/GSSG ratio. They also significantly depressed the single peak insulin response to tolbutamide by the isolated perfused pancreas as well as its synergistic action with glucose in isolated pancreatic islets. These results suggest that the effect of tolbutamide alone and its synergistic action with glucose could depend on the islet NADPH and GSH. In addition it appears that augmentation of tolbutamide action by glucose in insulin release is mediated by the provision of additional NADPH and GSH through glucose metabolism.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 384269     DOI: 10.1007/bf00506556

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  20 in total

1.  Oxidation in the NADP system and release of GSSG from hemoglobin-free perfused rat liver during peroxidatic oxidation of glutathione by hydroperoxides.

Authors:  H Sies; C Gerstenecker; H Menzel; L Flohé
Journal:  FEBS Lett       Date:  1972-10-15       Impact factor: 4.124

2.  Inhibition of p-chloromercuribenzoate- and glucose-induced insulin release in vitro by methylene blue, diamide, and tert-butyl hydroperoxide.

Authors:  H P Ammon; M S Akhtar; H Niklas; D Hegner
Journal:  Mol Pharmacol       Date:  1977-07       Impact factor: 4.436

3.  Insulin release from the perfused rat pancreas. Mode of action of tolbutamide.

Authors:  V Bowen; N R Lazarus
Journal:  Biochem J       Date:  1974-08       Impact factor: 3.857

4.  Mechanism of the TPNH-linked reduction of methemoglobin by methylene blue.

Authors:  M D Sass; C J Caruso; D R Axelrod
Journal:  Clin Chim Acta       Date:  1969-04       Impact factor: 3.786

5.  The pancreatic -cell recognition of insulin secretagogues. IV. Islet uptake of sulfonylureas.

Authors:  B Hellman; J Sehlin; I B Täljedal
Journal:  Diabetologia       Date:  1973-06       Impact factor: 10.122

6.  On the action of tolbutamide in normal man. II. Modulation of glucose-induced insulin release by tolbutamide.

Authors:  A Widström; E Cerasi
Journal:  Acta Endocrinol (Copenh)       Date:  1973-03

7.  Diamide, a new reagent for the intracellular oxidation of glutathione to the disulfide.

Authors:  N S Kosower; E M Kosower; B Wertheim; W S Correa
Journal:  Biochem Biophys Res Commun       Date:  1969-11-06       Impact factor: 3.575

8.  Kinetics of insulin release from the perfused rat pancreas caused by glucose, glucosamine, and galactose.

Authors:  R Landgraf; J Kotler-Brajtburg; F M Matschinsky
Journal:  Proc Natl Acad Sci U S A       Date:  1971-03       Impact factor: 11.205

9.  Useful agents for the study of glutathione metabolism in erythroyctes. Organic hydroperoxides.

Authors:  S K Srivastava; Y C Awasthi; E Beutler
Journal:  Biochem J       Date:  1974-05       Impact factor: 3.857

10.  On the possible role of thiol groups in the insulin-releasing action of mercurials, organic disulfides, alkylating agents, and sulfonylureas.

Authors:  B Hellman; A Lernmark; J Sehlin; M Söderberg; I B Täljedal
Journal:  Endocrinology       Date:  1976-11       Impact factor: 4.736

View more
  11 in total

Review 1.  Regulation of proinsulin synthesis in pancreatic islets and a new aspect to insulin-dependent diabetes.

Authors:  H Okamoto
Journal:  Mol Cell Biochem       Date:  1981-06-09       Impact factor: 3.396

2.  Effect of Methylene Blue on pyridine nucleotides and insulin secretion of rat pancreatic islets.

Authors:  H P Ammon; E J Verspohl
Journal:  Diabetologia       Date:  1979-07       Impact factor: 10.122

3.  Ca2+, NAD(P)H and membrane potential changes in pancreatic beta-cells by methyl succinate: comparison with glucose.

Authors:  Emma Heart; Gordon C Yaney; Richard F Corkey; Vera Schultz; Esthere Luc; Lihan Liu; Jude T Deeney; Orian Shirihai; Keith Tornheim; Peter J S Smith; Barbara E Corkey
Journal:  Biochem J       Date:  2007-04-01       Impact factor: 3.857

4.  Nitric oxide and hydroperoxide affect islet hormone release and Ca(2+) efflux.

Authors:  B Akesson; I Lundquist
Journal:  Endocrine       Date:  1999-08       Impact factor: 3.633

5.  High-dose nitric oxide inhalation increases lung injury after gastric aspiration.

Authors:  N D Nader; P R Knight; I Bobela; B A Davidson; K J Johnson; F Morin
Journal:  Anesthesiology       Date:  1999-09       Impact factor: 7.892

6.  Potentiation of glucose-induced insulin release by thiourea and thiourea derivatives.

Authors:  H P Ammon; M C Melien; T Pfäffle
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-09       Impact factor: 3.000

7.  Effect of diamide and reduced glutathione on the elevated levels of cyclic AMP in rat pancreatic islets exposed to glucose, p-chloromercuribenzoate and aminophylline.

Authors:  H P Ammon; S Heinzl; M Abdel-Hamid; H M Kallenberger; I Hagenloh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-06       Impact factor: 3.000

8.  Regulation of apoptosis by Caspases under oxidative stress conditions in mice testicular cells: in vitro molecular mechanism.

Authors:  Sumiti Kalia; M P Bansal
Journal:  Mol Cell Biochem       Date:  2008-11-01       Impact factor: 3.396

9.  A possible role of plasma glutathione in glucose-mediated insulin secretion: in vitro and in vivo studies in rats.

Authors:  H P Ammon; S Klumpp; A Fuss; E J Verspohl; H Jaeschke; A Wendel; P Müller
Journal:  Diabetologia       Date:  1989-11       Impact factor: 10.122

10.  Potentiation of the insulin-releasing capacity of tolbutamide by thiols: studies on the isolated perfused pancreas.

Authors:  H P Ammon; M Abdel-hamid
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-11       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.